Javascript must be enabled to continue!
Geographic Atrophy After Reabsorption of Pigment Epithelial Detachment (GARPED) Study
View through CrossRef
Abstract
Background: To describe the occurrence, rate of geographic atrophy (GA) expansion, and changes in visual acuity (VA) after reabsorption of subfoveal pigment epithelial detachments (PED).Methods: Included patients had reabsorption of a PED followed by GA. Patients underwent clinical examination with SD-OCT. Images were classified by size with grading occurring post reabsorption. VA was recorded pre reabsorption, post, and over time.Results: The average age of the cohort, consisting of 22 eyes from 19 participants, was 86.9 years at reabsorption. Prior to reabsorption, the VA was 20/80 and then declined to 20/200 (p=0.001). There was no significant VA change after the initial loss with reabsorption. The average initial lesion size of GA was 0.987 mm2 with an average growth rate of 0.274 mm/year.Conclusions: This study longitudinally examined GA growth rate in patients with reabsorbed PEDs. These patients started with a drusenoid or serous PED, had a dramatic reduction in vision and GA that occurred in place of the PED. These GA lesions have a slower growth rate and a smaller area of onset. They do not show significant VA change after reabsorption. As we enter the era of potential GA therapy, these patients may not benefit from current treatments under investigation.
Title: Geographic Atrophy After Reabsorption of Pigment Epithelial Detachment (GARPED) Study
Description:
Abstract
Background: To describe the occurrence, rate of geographic atrophy (GA) expansion, and changes in visual acuity (VA) after reabsorption of subfoveal pigment epithelial detachments (PED).
Methods: Included patients had reabsorption of a PED followed by GA.
Patients underwent clinical examination with SD-OCT.
Images were classified by size with grading occurring post reabsorption.
VA was recorded pre reabsorption, post, and over time.
Results: The average age of the cohort, consisting of 22 eyes from 19 participants, was 86.
9 years at reabsorption.
Prior to reabsorption, the VA was 20/80 and then declined to 20/200 (p=0.
001).
There was no significant VA change after the initial loss with reabsorption.
The average initial lesion size of GA was 0.
987 mm2 with an average growth rate of 0.
274 mm/year.
Conclusions: This study longitudinally examined GA growth rate in patients with reabsorbed PEDs.
These patients started with a drusenoid or serous PED, had a dramatic reduction in vision and GA that occurred in place of the PED.
These GA lesions have a slower growth rate and a smaller area of onset.
They do not show significant VA change after reabsorption.
As we enter the era of potential GA therapy, these patients may not benefit from current treatments under investigation.
Related Results
Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
Abstract
Background
To describe the occurrence, rate of geographic atrophy (GA) expansion, and changes in visual acuity (...
Using Cerebrospinal Fluid Improves Detection of Individual Brain Atrophy
Using Cerebrospinal Fluid Improves Detection of Individual Brain Atrophy
Abstract
Background
Clinical neuroradiologists routinely look for expansion of CSF spaces to help identify atrophy on patient MRI scans. In contrast, automated methods for...
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
Objective Insufficient physical activity, aerospace weight loss, and fixed treatment of fractures, tendons, and neuropathy, or the resulting muscle atrophy caused by reduced exerci...
Trooping the (School) Colour
Trooping the (School) Colour
Introduction
Throughout the early and mid-twentieth century, cadet training was a feature of many secondary schools and educational establishments across Australia, with countless ...
Epithelial-Myoepithelial Carcinoma of Salivary Glands: A Tertiary Center Experience
Epithelial-Myoepithelial Carcinoma of Salivary Glands: A Tertiary Center Experience
Abstract
Introduction
Epithelial-myoepithelial carcinoma (EMC) is a rare, biphasic malignant tumor affecting the salivary glands. It represents less than 1% of all salivary gland t...
PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Purpose:
To evaluate the size and location of macular atrophy in eyes with Type-1 neovascularization (NV) and age-related macular degeneration receiving chronic...
PATHWAYS TO GEOGRAPHIC ATROPHY IN NONNEOVASCULAR AGE-RELATED MACULAR DEGENERATION
PATHWAYS TO GEOGRAPHIC ATROPHY IN NONNEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Purpose:
To characterize and quantify the precursor lesions of geographic atrophy in eyes with age-related macular degeneration.
Metho...
SPINAL MUSCULAR ATROPHY CLINICAL FEATURES, CLASSIFICATION, NATURAL HISTORY, GENETICS, DIAGNOSIS, COMPLICATIONS AND TREATMENT OF THE DISEASE
SPINAL MUSCULAR ATROPHY CLINICAL FEATURES, CLASSIFICATION, NATURAL HISTORY, GENETICS, DIAGNOSIS, COMPLICATIONS AND TREATMENT OF THE DISEASE
Introduction: Spinal muscular atrophy (SMA) is a complex neuromuscular disorder, it is the most usual autosomal recessively inherited lethal neuromuscular disease in pediatrics, it...

